Organogenesis Holdings Inc (NASDAQ:ORGO) At $2.49: What To Do?

In last trading session, Organogenesis Holdings Inc (NASDAQ:ORGO) saw 3.0 million shares changing hands with its beta currently measuring 1.63. Company’s recent per share price level of $2.49 trading at -$0.02 or -0.80% at ring of the bell on the day assigns it a market valuation of $328.58M. That closing price of ORGO’s stock is at a discount of -88.76% from its 52-week high price of $4.70 and is indicating a premium of 24.5% from its 52-week low price of $1.88. Taking a look at company’s average trading volume volume of 849.24K if we extend that period to 3-months.

Organogenesis Holdings Inc (NASDAQ:ORGO) trade information

Upright in the red during last session for losing -0.80%, in the last five days ORGO remained trading in the green while hitting it’s week-highest on Thursday, 05/02/24 when the stock touched $2.49 price level, adding 14.73% to its value on the day. Organogenesis Holdings Inc’s shares saw a change of -39.12% in year-to-date performance and have moved 8.97% in past 5-day. Organogenesis Holdings Inc (NASDAQ:ORGO) showed a performance of -10.11% in past 30-days.

Organogenesis Holdings Inc (ORGO) estimates and forecasts

Statistics highlight that Organogenesis Holdings Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 11.16% of value to its shares in past 6 months, showing an annual growth rate of -125.00% while that of industry is 11.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 5.00% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 101.05M for the same. And 2 analysts are in estimates of company making revenue of 114.25M in the next quarter.

In 2024, company’s earnings growth rate is likely to be around -93.21% while estimates for its earnings growth in next 5 years are of 2.41%.

ORGO Dividends

Organogenesis Holdings Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.